STOK — Stoke Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00
- $657.32m
- $455.93m
- $8.78m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -32.3 | -52.2 | -85.8 | -101 | -105 |
Depreciation | |||||
Non-Cash Items | 1.93 | 6.81 | 17.9 | 24.6 | 27.2 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1.1 | 2.33 | 0.046 | 43 | -6.03 |
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -31.1 | -42.2 | -66.9 | -31.9 | -81.1 |
Capital Expenditures | -1.64 | -1.05 | -1.2 | -3.96 | -1.62 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.001 | 0 | -75.2 | -41.9 | 108 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -1.63 | -1.05 | -76.4 | -45.9 | 106 |
Financing Cash Flow Items | -2.46 | -0.485 | -0.002 | 45.3 | 52.1 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 150 | 108 | 1.28 | 46.4 | 53 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 117 | 64.8 | -142 | -31.3 | 77.9 |